Related Experiment Video
Updated: May 14, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Anti-Candida albicans natural products: convergent technologies revolutionizing discovery from bioactivity assessment
Di Zhang1,2, Xiaoxing Liu1,2, Xueqin Zhao1,2
1School of Life Sciences, Zhengzhou University, Zhengzhou, China.
Abstract:
Candida albicans represents a critical opportunistic fungal pathogen. The escalating prevalence of drug resistance necessitates urgent development of novel antifungal therapeutics. Natural products, characterized by structural diversity and bioactivity, constitute pivotal resources for antifungal drug discovery. Microbial-derived anti-C. albicans natural products (ACA-NPs) remain under-explored yet as highly promising resources. This review synthesizes advancements over the past 15 years regarding microbial ACA-NPs, emphasizing the strategies for multi-omics integration and data mining, in vitro and in vivo antifungal efficacy assessment, mechanisms of antifungal action, and future research directions and perspectives.
Related Concept Videos
Antifungal Agents
Drug Discovery: Overview

